These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15918671)

  • 1. [Prevention and screening of chronic renal failure].
    Bourel M; Ardaillou R
    Bull Acad Natl Med; 2004; 188(8):1455-68. PubMed ID: 15918671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the development and progression of renal diseases in disadvantaged populations: role of the renin-angiotensin system blockade.
    Maione A; Strippoli GF
    Ethn Dis; 2009; 19(1 Suppl 1):S1-86-9. PubMed ID: 19484883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemic of chronic kidney disease in India -what can be done?
    Prabahar MR; Chandrasekaran V; Soundararajan P
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):847-53. PubMed ID: 18711313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease in Cuba: epidemiological studies, integral medical care, and strategies for prevention.
    Almaguer M; Herrera R; Alfonzo J; Magrans C; Mañalich R; Martinez A; Davalos J; Perez-Oliva J; Landrove O
    Ren Fail; 2006; 28(8):671-6. PubMed ID: 17162425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study].
    de Francisco AL; De la Cruz JJ; Cases A; de la Figuera M; Egocheaga MI; Górriz JI; Llisterri JI; Marín R; Martínez Castelao A
    Nefrologia; 2007; 27(3):300-12. PubMed ID: 17725449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic approach prior to the onset of chronic renal insufficiency].
    Hannedouche T; Chantrel F; Fischer E
    Rev Prat; 2001 Feb; 51(4):372-7. PubMed ID: 11355600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III).
    Clase CM; Kiberd BA; Garg AX
    Nephron Clin Pract; 2007; 105(4):c178-84. PubMed ID: 17347576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and prevention of end stage renal disease in uruguay.
    Mazzuchi N; Schwedt E; Solá L; González C; Ferreiro A
    Ren Fail; 2006; 28(8):617-25. PubMed ID: 17162418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and risk factors of chronic renal diseases: a regional level of the problem].
    Smirnov AV; Dobronravov VA; Bodur-Oorzhak ASh; Zver'kov RV; Larionova VI; Glazkov PB; Bogdanova MA; Mnuskina MM; Kaiukov IG; Sanchi MN
    Ter Arkh; 2005; 77(6):20-7. PubMed ID: 16078595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do we need chronic kidney disease screening and which way to go?
    Mahdavi-Mazdeh M
    Iran J Kidney Dis; 2010 Oct; 4(4):275-81. PubMed ID: 20852366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and evaluation of chronic kidney disease.
    Snyder S; Pendergraph B
    Am Fam Physician; 2005 Nov; 72(9):1723-32. PubMed ID: 16300034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.